| Primary |
| Sleep Disorder |
40.0% |
| Alcohol Abuse |
20.0% |
| Anxiety |
20.0% |
| Psychotic Disorder |
20.0% |
|
| Grand Mal Convulsion |
100.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
28.0% |
| Product Used For Unknown Indication |
25.7% |
| Depression |
9.3% |
| Schizophrenia |
7.6% |
| Psychotic Disorder |
5.5% |
| Schizoaffective Disorder |
2.9% |
| Insomnia |
2.9% |
| Bipolar I Disorder |
2.7% |
| Schizophrenia, Paranoid Type |
1.5% |
| Abnormal Behaviour |
1.5% |
| Anxiety |
1.5% |
| Foetal Exposure During Pregnancy |
1.5% |
| Neuralgia |
1.4% |
| Delusional Disorder, Unspecified Type |
1.3% |
| Self Injurious Behaviour |
1.3% |
| Bipolar Disorder |
1.1% |
| Pain |
1.1% |
| Sleep Disorder |
1.1% |
| Hiv Infection |
1.1% |
| Antiemetic Supportive Care |
1.0% |
|
| Weight Increased |
12.0% |
| Somnolence |
9.3% |
| Suicide Attempt |
9.3% |
| Vomiting |
6.7% |
| Self Injurious Behaviour |
6.0% |
| Hyponatraemia |
5.3% |
| Weight Decreased |
5.3% |
| Rhabdomyolysis |
4.7% |
| Thrombocytopenia |
4.7% |
| Mesothelioma |
4.0% |
| Shock |
4.0% |
| Agranulocytosis |
3.3% |
| Cardio-respiratory Arrest |
3.3% |
| Death |
3.3% |
| Hypersomnia |
3.3% |
| Neutropenia |
3.3% |
| Sexual Dysfunction |
3.3% |
| Transaminases Increased |
3.3% |
| Cardiac Arrest |
2.7% |
| Completed Suicide |
2.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
29.1% |
| Product Used For Unknown Indication |
15.2% |
| Schizophrenia |
10.0% |
| Psychotic Disorder |
5.7% |
| Depression |
4.8% |
| Schizoaffective Disorder |
4.1% |
| Anxiety |
4.0% |
| Bipolar Disorder |
3.7% |
| Pain |
3.3% |
| Bipolar I Disorder |
3.0% |
| Epilepsy |
2.3% |
| Nausea |
2.2% |
| Mania |
1.9% |
| Non-small Cell Lung Cancer |
1.9% |
| Colorectal Cancer |
1.8% |
| Sleep Disorder |
1.8% |
| Acute Myeloid Leukaemia |
1.4% |
| Agitation |
1.3% |
| Diffuse Large B-cell Lymphoma Recurrent |
1.2% |
| Hypertension |
1.2% |
|
| Weight Increased |
19.4% |
| Vomiting |
9.2% |
| Tremor |
8.2% |
| Pulmonary Embolism |
6.6% |
| Thrombocytopenia |
5.1% |
| Withdrawal Syndrome |
5.1% |
| Delusion |
4.6% |
| Insomnia |
4.6% |
| Neutropenia |
3.6% |
| Pneumonia |
3.6% |
| Rhabdomyolysis |
3.6% |
| Transaminases Increased |
3.6% |
| Galactorrhoea |
3.1% |
| Hypertension |
3.1% |
| Hypophosphataemia |
3.1% |
| Septic Shock |
3.1% |
| Suicide Attempt |
3.1% |
| Acute Respiratory Distress Syndrome |
2.6% |
| Nausea |
2.6% |
| Overdose |
2.6% |
|
| Interacting |
| Product Used For Unknown Indication |
41.1% |
| Depression |
11.1% |
| Drug Use For Unknown Indication |
10.0% |
| Wound Infection |
7.8% |
| Psychotic Disorder |
5.6% |
| Anxiety Disorder |
4.4% |
| Angina Pectoris |
3.3% |
| Gastrooesophageal Reflux Disease |
3.3% |
| Mental Disorder |
3.3% |
| Type 1 Diabetes Mellitus |
3.3% |
| Drug Tolerance |
2.2% |
| Impulse-control Disorder |
2.2% |
| Attention Deficit/hyperactivity Disorder |
1.1% |
| Pain |
1.1% |
|
| Drug Interaction |
12.0% |
| Myalgia |
12.0% |
| Suicidal Ideation |
12.0% |
| Nystagmus |
8.0% |
| Overdose |
8.0% |
| Cardiac Arrest |
4.0% |
| Drug Withdrawal Syndrome Neonatal |
4.0% |
| Malaise |
4.0% |
| Purpura |
4.0% |
| Respiratory Depression |
4.0% |
| Sleep Disorder |
4.0% |
| Somnolence |
4.0% |
| Tachypnoea |
4.0% |
| Therapeutic Response Decreased |
4.0% |
| Torsade De Pointes |
4.0% |
| Urinary Retention |
4.0% |
| Volume Blood Decreased |
4.0% |
|
